BioCryst Pharmaceuticals, Inc. (BCRX) vs Mineralys Therapeutics, Inc. (MLYS)

A side-by-side comparison of BioCryst Pharmaceuticals, Inc. and Mineralys Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
BioCryst Pharmaceuticals, Inc. logo
BCRX
BioCryst Pharmaceuticals, Inc.
$2.02B
$7.96HealthcareDelayed quote: Oct 6, 2026, 10:55 AM EDT
Mineralys Therapeutics, Inc. logo
MLYS
Mineralys Therapeutics, Inc.
$2.01B
$22.78HealthcareDelayed quote: Oct 6, 2026, 10:55 AM EDT

Total return — BCRX vs MLYS

growth of $100 · dividends reinvested · last 4y
BCRX -23.0% (-6.3%/yr)MLYS +26.4% (+6.0%/yr)MLYS compounded faster over this window
50100150200250Start $100202420252026$77$126
BCRX MLYS

BCRX vs MLYS: by the numbers

  • •BCRX is the larger company ($2.02B vs $2.01B market cap).
  • •Both run net losses; MLYS's is the smaller (0.00% vs -40.90% net margin).

Metrics side by side

Valuation

MetricBCRXMLYS
P/S ratio2.15N/A
P/B ratioN/A3.64
FCF yield17.65%N/A

Profitability

MetricBCRXMLYS
Gross margin97.82%0.00%
Operating margin38.98%0.00%
Net margin-40.90%0.00%
ROEN/A-63.45%
ROIC-89.73%-57.17%

Growth (annualized)

MetricBCRXMLYS
Revenue CAGR (5Y)64.07%N/A
Total return CAGR (5Y)-10.02%N/A

Go deeper

Full BCRX analysisFull MLYS analysisInteractive comparison tool

Dig into the metrics

BioCryst Pharmaceuticals ROEMineralys Therapeutics ROEBioCryst Pharmaceuticals operating marginMineralys Therapeutics operating marginBioCryst Pharmaceuticals revenue growthMineralys Therapeutics revenue growthBioCryst Pharmaceuticals free cash flowMineralys Therapeutics free cash flow

BioCryst Pharmaceuticals & Mineralys Therapeutics appear in these rankings

Fastest Revenue Growth StocksHighest Operating Margin StocksHighest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.